Literature DB >> 4008919

Evaluation of coumatetralyl against two predominant murid species.

G Chopra, V R Parshad.   

Abstract

Coumatetralyl was evaluated in the laboratory against Bandicota bengalensis and Rattus rattus. Feeding tests with 0.0375% coumatetralyl baits produced 100% mortality after a single day feeding period in B. bengalensis and after a 10-day period in R. rattus. The anticoagulant bait is less palatable in comparison to plain bait. In the case of R. rattus, LFP50 and LFP98 and their 95% confidence limits were 3.89 (2.62-5.77) days and 11.22 (6.1-20.65) days respectively. Median period of survival and its 95% confidence limits of B. bengalensis and R. rattus were 4.7 (3.85-5.7) days and 11.2 (9.33-13.44) days respectively.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4008919      PMCID: PMC2129486          DOI: 10.1017/s0022172400061556

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  3 in total

1.  A method for rapid graphic solution of time-per cent effect curves.

Authors:  J T LITCHFIELD
Journal:  J Pharmacol Exp Ther       Date:  1949-12       Impact factor: 4.030

2.  The susceptibility of Bandicota bengalensis from Rangoon, Burma to several anticoagulant rodenticides.

Authors:  J E Brooks; P T Htun; H Naing
Journal:  J Hyg (Lond)       Date:  1980-02

3.  The susceptibility of Tatera indica, Nesokia indica and Bandicota bengalensis to three anticoagulant rodenticides.

Authors:  J H Greaves; A B Rehman
Journal:  J Hyg (Lond)       Date:  1977-02
  3 in total
  2 in total

1.  The susceptibility of Rattus rattus and Bandicota bengalensis to a new anticoagulant rodenticide, flocoumafen.

Authors:  V R Parshad; G Chopra
Journal:  J Hyg (Lond)       Date:  1986-06

2.  Quantitative method for analysis of six anticoagulant rodenticides in faeces, applied in a case with repeated samples from a dog.

Authors:  Kristin Opdal Seljetun; Elin Eliassen; Ritva Karinen; Lars Moe; Vigdis Vindenes
Journal:  Acta Vet Scand       Date:  2018-01-17       Impact factor: 1.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.